| ²é¿´: 712 | »Ø¸´: 2 | ||
maolin1900ľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇëÎÊÇëÎÊ£ºBetween-Arm Difference Ôõô·£¿ ÊDz»ÊÇͳ¼ÆÑ§·½ÃæµÄ´Ê»ã£¿ ÒÑÓÐ1È˲ÎÓë
|
|
ÇëÎÊ£ºBetween-Arm Difference Ôõô·£¿ ÊDz»ÊÇͳ¼ÆÑ§·½ÃæµÄ´Ê»ã£¿ |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸985£¬±¾¿Æ211£¬0817»¯Ñ§¹¤³ÌÓë¼¼Êõ319Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ7È˻ظ´
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ17È˻ظ´
267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817µ÷¼Á
ÒѾÓÐ3È˻ظ´
½¹ÂÇ
ÒѾÓÐ13È˻ظ´
lightfeather
¾èÖú¹ó±ö (³õÈëÎÄ̳)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 1106.6
- ºì»¨: 1
- Ìû×Ó: 19
- ÔÚÏß: 24.8Сʱ
- ³æºÅ: 325166
- ×¢²á: 2007-03-17
- רҵ: ÐÇϵºÍÀàÐÇÌå
2Â¥2014-10-22 19:31:17
maolin1900
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1562
- ºì»¨: 1
- Ìû×Ó: 123
- ÔÚÏß: 58.5Сʱ
- ³æºÅ: 383073
- ×¢²á: 2007-05-26
- רҵ: ÁÙ´²Ò©Àí
|
ллÁË£¬ÔÎÄÊÇÕª×Ô·²µÂËûÄáµÄfda˵Ã÷Êé²»Á¼·´Ó¦£ºTable 1 - Per-Patient Incidence of Selected Adverse Reactions Occurring at a Higher Incidence in CAPRELSA-Treated Patients During Randomized Treatment [Between-Arm Difference of ¡Ý 5% (All Grades)1] µ«ÊÇÈç¹û·ÒëΪ±Û¼ä²îÒ죬ÄÇô¸¹ÐºÖ®ÀàµÄ²»Á¼·´Ó¦»áÓв»Á¼·´Ó¦Ã´£¿ |
3Â¥2014-10-23 08:56:18













»Ø¸´´ËÂ¥
50